U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316309) titled 'CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer' on Dec. 18, 2025.
Brief Summary: This prospective observational study aims to evaluate the clinical value of CXCR4-targeted PET/CT imaging in patients with limited-stage small cell lung cancer (LS-SCLC).
Patients diagnosed with LS-SCLC at Shandong Cancer Hospital and Institute underwent [18F]AlF-NOTA-QHY-04 PET/CT imaging before receiving standard concurrent chemoradiotherapy. Imaging findings were analyzed and correlated with clinical outcomes, including progression-free survival, to explore the potential role of CXCR4 PET/CT as a prognostic imaging biomar...